Reiterates 2025 guidance of $80 million to $90 million in revenue and mid-40s percentage gross margin - SAN DIEGO, CA, March 31, 2025 (GLOBE ...
Rapid Enrollment and Dosing of First Patients in PRECISE-AD Trial Underscores the Unmet Need for Better Treatment Options for Alzheimer’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback